Patent: 10,391,096
✉ Email this page to a colleague
Summary for Patent: 10,391,096
| Title: | Method for treating thrombotic disorders using quercetin-containing compositions |
| Abstract: | A method for treating thrombotic disorders using a composition containing quercetin, together with one or more of vitamin B, vitamin C, and folic acid. Also disclosed is a method of improving the efficacy of a blood thinning medication by co-administering a composition containing quercetin, together with one or more of vitamin B, vitamin C, and folic acid to a subject being treated with a blood thinning medication. |
| Inventor(s): | Lines Thomas Christian |
| Assignee: | Quercegen Pharmaceuticals LLC |
| Application Number: | US13272508 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,391,096
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bausch Health Us, Llc | IPRIVASK | desirudin | For Injection | 021271 | April 04, 2003 | 10,391,096 | 2031-10-13 |
| Eli Lilly And Company | XIGRIS | drotrecogin alfa | Injection | 125029 | November 21, 2001 | 10,391,096 | 2031-10-13 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
